Early Detection,
a way to protect your loved ones.
As a member of the CancerX, CUBEBIO attended CancerX Inaugural Member Summit 2023 held in HHS(Health and Human Services) Mary E. Switzer Building, Washington D.C. on the 7th of September. Approximately 150 personnels from global corporations and the US Government Departments gathered to discuss business management and measures in regards to reducing cancer mortality. CUBEBIO had also acquired successful clinical trial results in urine-based pancreatic cancer diagnosis co-conducted with SNUH(Seoul National University Hospital) and thus attracted $46.7Mn investment. READ MORE
Close for 1day Closescroll
About
CUBEBIO
R&D
Unlike healthy cells, amino acid, glucose, nucleic acid precursor, protein, and other elements are metabolized in larger quantities and excreted in urine at different concentrations in the development of cancer. We can check the existence or non-existence of cancer by measuring these concentrations.Press Release
View More